Effectiveness of Digital Marketing Strategies to Improve Adherence to Chronic Medications

NCT ID: NCT06599333

Last Updated: 2025-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

192 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-15

Study Completion Date

2024-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the Middle East, particularly Lebanon, the adoption of digital health interventions has been growing. Mobile health (mHealth) platforms, social media campaigns, and telemedicine services are being integrated into healthcare systems. However, while digital marketing for health promotion is gaining traction globally, few studies have specifically examined its impact on medication adherence in Lebanon. The e-MedAL Study aims to fill this gap by evaluating whether tailored digital marketing strategies can foster better adherence among patients with chronic diseases, taking into account the local healthcare infrastructure and cultural context. Lebanon faces unique challenges in managing chronic diseases due to its healthcare system, which is fragmented and highly privatized. The ongoing economic crisis, coupled with the COVID-19 pandemic, has placed additional stress on healthcare delivery, making it difficult for patients to maintain consistent access to medications. Moreover, the high cost of chronic medications, coupled with the population\'s general reliance on out-of-pocket expenditures, contributes to non-adherence.

Exploring cost-effective and scalable interventions like digital marketing becomes vital in this context. Lebanon has a high internet and mobile phone penetration rate, which presents an opportunity for leveraging digital tools to promote health. By utilizing culturally tailored messaging and communication strategies, the e-MedAL Study has the potential to improve medication adherence rates significantly. This, in turn, would alleviate the burden on healthcare resources, enhance patient outcomes, and reduce the economic impact of poorly managed chronic diseases in the country. Furthermore, the success of this initiative could serve as a model for other countries in the region facing similar healthcare challenges. Lebanon's diverse and tech-savvy population makes it an ideal test case for assessing the role of digital marketing in healthcare, particularly in resource-constrained settings.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study focuses on the role of digital marketing in improving medication adherence for chronic diseases in Lebanon. Here's a detailed breakdown of the study:

1. Study Overview and Purpose Chronic diseases like diabetes, hypertension, and cardiovascular disorders are growing global health concerns. One of the biggest challenges is ensuring long-term adherence to prescribed treatments, which, if not followed, leads to poor health outcomes and higher healthcare costs .

The e-MedAL study investigates how digital marketing strategies-such as mobile applications, social media campaigns, and online education-can improve medication adherence among patients in Lebanon . It evaluates the local healthcare infrastructure and cultural factors affecting adherence.
2. State of Digital Marketing in Healthcare Digital marketing has revolutionized how healthcare providers engage with patients. By offering more personalized and interactive communication channels, it provides opportunities to boost medication adherence. Digital tools like reminders, educational campaigns, and behavioral nudges have been shown to improve adherence by as much as 17% across various chronic diseases .

Lebanon's high internet penetration presents an opportunity to implement these strategies. However, the country also faces unique challenges, such as a fragmented healthcare system, economic difficulties, and a reliance on out-of-pocket payments, making adherence a significant issue .
3. Research Format and Methodology (PECO) Population: Patients residing in Lebanon who have been taking chronic medications for at least six months.

Exposure: The use of digital marketing strategies to improve medication adherence.

Comparison: A questionnaire-based assessment to evaluate patients' perceptions and readiness to adopt digital marketing strategies.

Outcomes: Correlation between the effectiveness of digital strategies and patient adherence, along with demographic characteristics.
4. Questionnaire Sections General Characteristics: Participants provide demographic information such as age, education, smoking habits, and economic status .

Medical and Medication History: Participants detail their chronic conditions, medication routines, and healthcare provider preferences .

Adherence Assessment: Using a Likert scale, participants assess how closely they follow their prescribed medication regimen .

Effectiveness of Digital Marketing: This section assesses how digital reminders, educational content, social media, and telemedicine services influence medication adherence .

Perceived Barriers: Participants indicate potential challenges in using digital health tools, such as internet access, privacy concerns, and trust in digital channels .
5. Study Timeline and Outcome The study began on July 15th, 2024, and is ongoing (IRB Faculty of Pharmacy, Lebanese University).

The expected outcomes include a thesis, a scientific publication, and possibly a presentation at an international conference .

The study aims to provide insights that could serve as a model for other countries facing similar healthcare challenges, particularly in resource-constrained settings like Lebanon.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adherence to Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

Patients coming to community pharmacies and taking at least the same medication for 6 months

Adherence to Care

Intervention Type BEHAVIORAL

Questionnaire to assess the perception and readiness of patients in Lebanon towards the effectiveness of digital marketing strategies to improve their adherence to medications they take chronically

The following sections will be considered:

* General Characteristics of the Participants
* Medical and medication history
* Assessment of adherence to chronic medications (Likert scale)
* Digital Marketing Strategies to improve adherence to chronic medications (Likert scale)
* Perceived barriers to adopting digital marketing strategies in Lebanon (Likert scale)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Adherence to Care

Questionnaire to assess the perception and readiness of patients in Lebanon towards the effectiveness of digital marketing strategies to improve their adherence to medications they take chronically

The following sections will be considered:

* General Characteristics of the Participants
* Medical and medication history
* Assessment of adherence to chronic medications (Likert scale)
* Digital Marketing Strategies to improve adherence to chronic medications (Likert scale)
* Perceived barriers to adopting digital marketing strategies in Lebanon (Likert scale)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients taking the same medication for at least six months
* Lebanese patients
* Those who agree to participate in the study

Exclusion Criteria

* Those with electronic illiteracy
* Those who are not themselves responsible for purchasing the medications
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lebanese University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Georges Hatem

Associate Clinical and Epidemiological Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Georges Hatem

Role: PRINCIPAL_INVESTIGATOR

Lebanese University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lebanese University

Beirut, , Lebanon

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Lebanon

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18/24/D

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.